Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSwitching who supplies your Mounjaro is more straightforward than most people expect. As a prescription-only medicine, tirzepatide always requires clinical assessment before each supply — which means a new provider will review your case afresh, but that review is routine rather than an obstacle. You do not need permission from your current provider to move, and there is no formal transfer form to complete. What you do need is a clear picture of where you are in treatment, and a new prescriber who will look at that picture properly before approving your next pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before you contact a new provider, spend two minutes pulling together the basics: which dose you are currently on, how many weeks you have been at that dose, and whether you have had any side effects worth flagging. A question our prescribers hear most weeks is whether patients need a letter from their previous clinic. The short answer is no, but having your own record means the clinical review at your new provider can be done properly rather than speculatively.
If you have a repeat prescription or a recent dispatch confirmation showing the dose, keep it handy. Some providers, including our clinical team at nume, will ask you to photograph the pen label or upload a previous prescription as evidence when you are transferring mid-treatment rather than starting fresh. This is not bureaucracy for its own sake: it prevents a prescriber from inadvertently restarting you at 2.5 mg when you have already tolerated 7.5 mg for eight weeks. The clinical review exists to protect you, and feeding it accurate information is the single most useful thing you can do.
You do not need to tell your current provider you are leaving, and there is no cancellation procedure, since Mounjaro is a prescription medicine rather than a subscription product in the regulatory sense, each order stands alone. That said, if you are mid-pen, finishing it before switching avoids any gap in treatment.
Not all online Mounjaro providers operate to the same standard. The minimum legal requirement is that the prescribing is done by a registered prescriber and the dispensing is carried out by a GPhC-registered pharmacy, the General Pharmaceutical Council maintains a public register you can search by name or registration number. Any provider that cannot point you to a verifiable entry on that register is one to walk away from.
Beyond the legal minimum, look at how the provider handles dose increases. A legitimate service will ask for evidence before moving you up, weight trend, how you have tolerated the current dose, time elapsed. If a provider offers to jump you to a higher dose on the basis of a short questionnaire alone, that is a clinical red flag. The qualities that define a trustworthy Mounjaro provider go beyond price and include identity verification, live weight checks, and a named prescriber reviewing each order.
The MHRA has issued repeated warnings about counterfeit tirzepatide circulating in the UK, fake pens that have reached consumers through unverified online sellers. If you are still weighing up your options, our guide to the best site to buy Mounjaro explains what to look for so you can verify a pharmacy before placing an order. You can also report any suspect seller directly via the MHRA's Yellow Card scheme.
Once you have chosen a provider, the process mirrors an initial consultation with one extra layer: declaring your transfer status. Be specific. State the dose you are on, confirm how recently you received your last pen, and mention any side effects that have been relevant during treatment. Omitting this information (perhaps to avoid being restarted at a lower dose) creates a clinical risk that is not worth taking.
A prescriber assessing a transfer patient is not looking for reasons to turn you away; they are building a picture of where you are in treatment so they can continue it safely. If you are on 10 mg and have been tolerating it well for six weeks, a thorough prescriber will generally continue at that dose rather than reset the clock. The review is the point, not a hurdle in front of it.
Delivery, aftercare and ongoing dose reviews vary by provider. Before committing, it is worth understanding what is included in the price you pay, whether clinical re-review before each repeat is standard practice, and how to reach the prescribing team if you have a question between orders. You can read more about what different services include on our overview of UK Mounjaro providers, and if cost is part of your thinking, our Mounjaro price guide gives an honest picture of the market.
Once your new provider has reviewed your case and issued a prescription, the treatment continues as before, same weekly injection schedule, same lifestyle principles, same plan to work toward the highest dose you tolerate well. The NHS patient information for tirzepatide is a useful reference for storage, injection technique and what to do if you miss a dose; your new prescriber's aftercare team is the right first call for anything clinical.
Keep a simple note going forward: date of each injection, current dose, any side effects. It takes thirty seconds and makes every future clinical review (whether that is your next repeat or a provider switch two years from now) faster and more accurate. Mounjaro is a long-term treatment for most people who use it; the infrastructure around that treatment is worth maintaining as carefully as the treatment itself. If you want to explore your options before making any decision, our page on how to change your Mounjaro provider covers the more practical questions in detail, and our guide to switching Mounjaro provider sits alongside it with further information.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.